| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sweet Syndrome | 4 | 2014 | 59 | 0.960 |
Why?
|
| Skin Neoplasms | 25 | 2017 | 5849 | 0.950 |
Why?
|
| Skin Diseases | 8 | 2017 | 1088 | 0.920 |
Why?
|
| Melanoma | 28 | 2017 | 5719 | 0.870 |
Why?
|
| Pathology, Clinical | 3 | 2017 | 377 | 0.850 |
Why?
|
| Skin Diseases, Bacterial | 2 | 2017 | 68 | 0.850 |
Why?
|
| Immunoglobulin A | 3 | 2015 | 995 | 0.800 |
Why?
|
| Biodiversity | 2 | 2016 | 346 | 0.800 |
Why?
|
| Microscopy | 2 | 2017 | 901 | 0.750 |
Why?
|
| Fluorescent Antibody Technique, Direct | 3 | 2019 | 67 | 0.720 |
Why?
|
| Mycobacterium Infections | 2 | 2014 | 123 | 0.720 |
Why?
|
| Skin | 14 | 2020 | 4489 | 0.680 |
Why?
|
| Lupus Erythematosus, Systemic | 4 | 2017 | 2159 | 0.640 |
Why?
|
| Basal Cell Nevus Syndrome | 2 | 2016 | 40 | 0.620 |
Why?
|
| Vasculitis, Leukocytoclastic, Cutaneous | 2 | 2018 | 43 | 0.600 |
Why?
|
| Search Engine | 2 | 2018 | 145 | 0.580 |
Why?
|
| Frozen Sections | 1 | 2017 | 153 | 0.550 |
Why?
|
| Nevus, Pigmented | 5 | 2017 | 227 | 0.540 |
Why?
|
| Melanocytes | 12 | 2015 | 515 | 0.540 |
Why?
|
| Thromboangiitis Obliterans | 1 | 2016 | 10 | 0.530 |
Why?
|
| Dermatomyositis | 2 | 2017 | 261 | 0.520 |
Why?
|
| Scleroderma, Localized | 1 | 2017 | 85 | 0.520 |
Why?
|
| Dermatitis Herpetiformis | 1 | 2015 | 23 | 0.510 |
Why?
|
| Still's Disease, Adult-Onset | 1 | 2015 | 24 | 0.510 |
Why?
|
| Soft Tissue Infections | 1 | 2017 | 167 | 0.500 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2015 | 113 | 0.490 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2016 | 150 | 0.480 |
Why?
|
| Extinction, Biological | 1 | 2014 | 31 | 0.450 |
Why?
|
| Fluorescent Antibody Technique | 6 | 2017 | 2476 | 0.440 |
Why?
|
| Calciphylaxis | 1 | 2015 | 130 | 0.430 |
Why?
|
| Disease Reservoirs | 1 | 2014 | 124 | 0.430 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 330 | 0.420 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2015 | 196 | 0.420 |
Why?
|
| Zoonoses | 1 | 2014 | 181 | 0.410 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 9 | 2014 | 266 | 0.410 |
Why?
|
| Kidney Neoplasms | 11 | 1999 | 4274 | 0.390 |
Why?
|
| Exanthema | 2 | 2015 | 502 | 0.390 |
Why?
|
| Lupus Erythematosus, Cutaneous | 2 | 2018 | 80 | 0.380 |
Why?
|
| Vasculitis | 5 | 2018 | 527 | 0.380 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2015 | 2844 | 0.370 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2016 | 618 | 0.370 |
Why?
|
| Sweat Gland Neoplasms | 4 | 2015 | 110 | 0.360 |
Why?
|
| Medical Informatics | 1 | 2018 | 745 | 0.360 |
Why?
|
| Sensitivity and Specificity | 15 | 2017 | 14652 | 0.350 |
Why?
|
| Staining and Labeling | 2 | 2014 | 1072 | 0.350 |
Why?
|
| Diagnosis, Differential | 28 | 2018 | 12976 | 0.350 |
Why?
|
| Carcinoma, Renal Cell | 11 | 1999 | 3181 | 0.350 |
Why?
|
| Politics | 1 | 2016 | 822 | 0.320 |
Why?
|
| Carcinoma, Papillary | 4 | 1998 | 788 | 0.310 |
Why?
|
| Autoimmune Diseases | 2 | 2019 | 2226 | 0.310 |
Why?
|
| Adenoma, Sweat Gland | 2 | 2015 | 18 | 0.300 |
Why?
|
| Carcinoma, Squamous Cell | 7 | 2015 | 4044 | 0.290 |
Why?
|
| Vaginal Smears | 7 | 2001 | 513 | 0.290 |
Why?
|
| Vulvar Neoplasms | 5 | 2018 | 270 | 0.290 |
Why?
|
| Biopsy, Needle | 11 | 2001 | 1628 | 0.290 |
Why?
|
| Uterine Cervical Neoplasms | 7 | 2015 | 2047 | 0.270 |
Why?
|
| Humans | 140 | 2020 | 765968 | 0.270 |
Why?
|
| Angiomyolipoma | 2 | 2016 | 190 | 0.260 |
Why?
|
| Carcinoma in Situ | 4 | 2008 | 779 | 0.260 |
Why?
|
| Cytological Techniques | 2 | 1998 | 220 | 0.260 |
Why?
|
| Immunocompromised Host | 3 | 2018 | 866 | 0.260 |
Why?
|
| Acanthosis Nigricans | 2 | 2004 | 49 | 0.260 |
Why?
|
| Middle Aged | 71 | 2020 | 223009 | 0.250 |
Why?
|
| Head and Neck Neoplasms | 3 | 2014 | 2921 | 0.250 |
Why?
|
| Communication | 2 | 2018 | 3916 | 0.240 |
Why?
|
| Abscess | 1 | 2008 | 606 | 0.240 |
Why?
|
| Sarcoma, Clear Cell | 2 | 2006 | 75 | 0.240 |
Why?
|
| Fasciitis | 2 | 1996 | 68 | 0.230 |
Why?
|
| Keratosis, Seborrheic | 3 | 2012 | 31 | 0.230 |
Why?
|
| Neutrophils | 2 | 2013 | 3776 | 0.230 |
Why?
|
| Nevus, Blue | 2 | 2002 | 45 | 0.230 |
Why?
|
| Cicatrix | 1 | 2010 | 798 | 0.220 |
Why?
|
| Female | 86 | 2020 | 396112 | 0.220 |
Why?
|
| Adult | 62 | 2020 | 223044 | 0.210 |
Why?
|
| Lyme Disease | 4 | 2014 | 631 | 0.210 |
Why?
|
| DNA-Binding Proteins | 6 | 2006 | 9601 | 0.210 |
Why?
|
| Adenocarcinoma | 8 | 2008 | 6364 | 0.210 |
Why?
|
| Antigens, CD | 5 | 2015 | 4025 | 0.210 |
Why?
|
| Neoplasm Metastasis | 7 | 2016 | 4893 | 0.210 |
Why?
|
| Public Health | 1 | 2016 | 2680 | 0.210 |
Why?
|
| Male | 68 | 2020 | 363698 | 0.200 |
Why?
|
| Carcinoma, Merkel Cell | 3 | 2014 | 328 | 0.200 |
Why?
|
| Transcription Factors | 8 | 2016 | 12131 | 0.200 |
Why?
|
| Immunohistochemistry | 18 | 2017 | 11022 | 0.200 |
Why?
|
| Paget Disease, Extramammary | 2 | 2015 | 52 | 0.190 |
Why?
|
| Adenoma, Oxyphilic | 3 | 1998 | 149 | 0.190 |
Why?
|
| Granular Cell Tumor | 1 | 2001 | 46 | 0.190 |
Why?
|
| Myiasis | 1 | 2001 | 15 | 0.180 |
Why?
|
| Skin Diseases, Parasitic | 1 | 2001 | 14 | 0.180 |
Why?
|
| Diptera | 1 | 2001 | 51 | 0.180 |
Why?
|
| Bone Neoplasms | 3 | 1998 | 2567 | 0.180 |
Why?
|
| Desmoplakins | 1 | 2020 | 65 | 0.180 |
Why?
|
| Cell Adhesion Molecules | 2 | 1997 | 1612 | 0.180 |
Why?
|
| Angiomyoma | 2 | 1997 | 13 | 0.170 |
Why?
|
| Hedgehog Proteins | 2 | 2016 | 774 | 0.170 |
Why?
|
| Ultraviolet Rays | 3 | 2014 | 1102 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2016 | 8611 | 0.170 |
Why?
|
| Neoplasm Proteins | 4 | 2001 | 3596 | 0.170 |
Why?
|
| Biopsy | 11 | 2017 | 6763 | 0.170 |
Why?
|
| Paraneoplastic Syndromes | 2 | 2012 | 156 | 0.160 |
Why?
|
| Neoplasms, Multiple Primary | 3 | 2015 | 587 | 0.160 |
Why?
|
| Aged | 39 | 2020 | 171117 | 0.160 |
Why?
|
| Adenoma | 3 | 1999 | 2152 | 0.160 |
Why?
|
| Necrosis | 3 | 2017 | 1617 | 0.160 |
Why?
|
| Smoking | 1 | 2016 | 9081 | 0.160 |
Why?
|
| Borrelia burgdorferi Group | 3 | 1998 | 97 | 0.160 |
Why?
|
| 5-Methylcytosine | 2 | 2017 | 148 | 0.160 |
Why?
|
| Mutation | 6 | 2020 | 30198 | 0.160 |
Why?
|
| Carcinoma, Basal Cell | 4 | 2014 | 566 | 0.160 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2020 | 164 | 0.160 |
Why?
|
| Parotid Diseases | 1 | 1999 | 50 | 0.150 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 2012 | 3646 | 0.150 |
Why?
|
| Chondroblastoma | 1 | 1998 | 48 | 0.150 |
Why?
|
| Myoma | 1 | 1998 | 7 | 0.150 |
Why?
|
| Nevus | 2 | 2014 | 205 | 0.150 |
Why?
|
| Histiocytoma, Benign Fibrous | 2 | 2014 | 66 | 0.150 |
Why?
|
| Antigens, Neoplasm | 4 | 2001 | 2002 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 7 | 2015 | 6069 | 0.150 |
Why?
|
| Histiocytosis, Non-Langerhans-Cell | 1 | 2018 | 24 | 0.150 |
Why?
|
| Epidermodysplasia Verruciformis | 1 | 2018 | 23 | 0.150 |
Why?
|
| Myofibromatosis | 1 | 1998 | 28 | 0.150 |
Why?
|
| Bile Duct Diseases | 1 | 1998 | 99 | 0.150 |
Why?
|
| Levamisole | 1 | 2018 | 37 | 0.150 |
Why?
|
| Inhibins | 1 | 1998 | 211 | 0.150 |
Why?
|
| Chromosome Inversion | 1 | 1998 | 120 | 0.150 |
Why?
|
| Hair Follicle | 2 | 2014 | 224 | 0.150 |
Why?
|
| Papillomaviridae | 4 | 2018 | 1141 | 0.150 |
Why?
|
| Neoplasms, Second Primary | 2 | 2008 | 1050 | 0.150 |
Why?
|
| Ascitic Fluid | 1 | 1998 | 190 | 0.150 |
Why?
|
| Genes, Dominant | 1 | 2020 | 856 | 0.150 |
Why?
|
| Oncogenes | 3 | 2011 | 1235 | 0.150 |
Why?
|
| Hemangiopericytoma | 1 | 1998 | 71 | 0.150 |
Why?
|
| Epidermis | 3 | 2012 | 538 | 0.140 |
Why?
|
| Parotid Gland | 1 | 1999 | 177 | 0.140 |
Why?
|
| Glomus Tumor | 1 | 1998 | 63 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1998 | 371 | 0.140 |
Why?
|
| Leukemic Infiltration | 1 | 1997 | 48 | 0.140 |
Why?
|
| Piperazines | 3 | 2018 | 2549 | 0.140 |
Why?
|
| Mouth Diseases | 1 | 2019 | 240 | 0.140 |
Why?
|
| Arthralgia | 2 | 2018 | 459 | 0.140 |
Why?
|
| Pleural Effusion, Malignant | 1 | 1998 | 109 | 0.140 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 1998 | 161 | 0.140 |
Why?
|
| Chondrosarcoma, Mesenchymal | 1 | 1996 | 13 | 0.140 |
Why?
|
| Borrelia Infections | 1 | 1996 | 18 | 0.140 |
Why?
|
| Drug Contamination | 1 | 2018 | 152 | 0.130 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 1996 | 44 | 0.130 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2017 | 86 | 0.130 |
Why?
|
| Retrospective Studies | 21 | 2017 | 81514 | 0.130 |
Why?
|
| Algorithms | 1 | 2017 | 14071 | 0.130 |
Why?
|
| Proto-Oncogene Proteins B-raf | 4 | 2012 | 2054 | 0.130 |
Why?
|
| Genital Diseases, Female | 1 | 2017 | 193 | 0.130 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 1997 | 104 | 0.130 |
Why?
|
| Pilomatrixoma | 2 | 2014 | 26 | 0.130 |
Why?
|
| Boron Compounds | 1 | 2018 | 196 | 0.130 |
Why?
|
| Myxoma | 1 | 1997 | 115 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2016 | 2796 | 0.130 |
Why?
|
| Inclusion Bodies | 1 | 1997 | 277 | 0.130 |
Why?
|
| Pemphigoid, Bullous | 1 | 2017 | 109 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2010 | 1061 | 0.120 |
Why?
|
| Scleromyxedema | 1 | 2014 | 8 | 0.120 |
Why?
|
| PubMed | 1 | 2015 | 131 | 0.120 |
Why?
|
| Paraplegia | 1 | 2015 | 158 | 0.120 |
Why?
|
| Pelvic Neoplasms | 1 | 1997 | 247 | 0.120 |
Why?
|
| Internet | 2 | 2018 | 3106 | 0.120 |
Why?
|
| Hyperthyroidism | 1 | 1997 | 294 | 0.120 |
Why?
|
| Skin Pigmentation | 2 | 2007 | 279 | 0.120 |
Why?
|
| Lymphatic Metastasis | 3 | 2014 | 2887 | 0.120 |
Why?
|
| Cocaine-Related Disorders | 1 | 2018 | 459 | 0.120 |
Why?
|
| Granuloma Annulare | 1 | 2014 | 31 | 0.120 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2016 | 207 | 0.120 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2015 | 150 | 0.120 |
Why?
|
| Glycine | 1 | 2018 | 672 | 0.110 |
Why?
|
| Soft Tissue Neoplasms | 2 | 2001 | 1165 | 0.110 |
Why?
|
| Cytodiagnosis | 1 | 1998 | 453 | 0.110 |
Why?
|
| Rosaniline Dyes | 1 | 2014 | 52 | 0.110 |
Why?
|
| Facial Neoplasms | 1 | 2015 | 127 | 0.110 |
Why?
|
| Deer | 1 | 2014 | 15 | 0.110 |
Why?
|
| Epidural Abscess | 1 | 2015 | 96 | 0.110 |
Why?
|
| Sebaceous Gland Neoplasms | 1 | 2014 | 38 | 0.110 |
Why?
|
| Pleural Effusion | 1 | 1997 | 346 | 0.110 |
Why?
|
| Complex Regional Pain Syndromes | 1 | 2015 | 123 | 0.110 |
Why?
|
| Graft vs Host Reaction | 1 | 2014 | 100 | 0.110 |
Why?
|
| Connective Tissue Diseases | 1 | 2017 | 284 | 0.110 |
Why?
|
| Cervix Uteri | 4 | 1999 | 579 | 0.110 |
Why?
|
| Mycosis Fungoides | 1 | 2015 | 155 | 0.110 |
Why?
|
| Radiculopathy | 1 | 1996 | 205 | 0.110 |
Why?
|
| Hydroxamic Acids | 1 | 2016 | 483 | 0.110 |
Why?
|
| Indoles | 3 | 2016 | 1839 | 0.110 |
Why?
|
| Observer Variation | 3 | 2003 | 2615 | 0.110 |
Why?
|
| Neoplasm Staging | 4 | 2016 | 11206 | 0.110 |
Why?
|
| Urbanization | 1 | 2014 | 101 | 0.110 |
Why?
|
| Cytosine | 1 | 2014 | 213 | 0.110 |
Why?
|
| Chromatin | 3 | 2001 | 2980 | 0.100 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2014 | 176 | 0.100 |
Why?
|
| Iodine Radioisotopes | 1 | 1997 | 1029 | 0.100 |
Why?
|
| Serpins | 1 | 2014 | 245 | 0.100 |
Why?
|
| Cerebrospinal Fluid | 1 | 1996 | 539 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 7 | 2016 | 3602 | 0.100 |
Why?
|
| Skin Diseases, Vascular | 1 | 2013 | 42 | 0.100 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1997 | 540 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 6 | 2012 | 1701 | 0.100 |
Why?
|
| Cocaine | 1 | 2018 | 946 | 0.100 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2013 | 1624 | 0.100 |
Why?
|
| Integrin alpha6beta4 | 1 | 2012 | 31 | 0.100 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 2012 | 76 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 3 | 2017 | 9249 | 0.100 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1996 | 664 | 0.100 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2015 | 456 | 0.100 |
Why?
|
| Adolescent | 19 | 2020 | 88835 | 0.100 |
Why?
|
| Pigmentation Disorders | 1 | 2012 | 106 | 0.100 |
Why?
|
| MART-1 Antigen | 3 | 2001 | 65 | 0.100 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 1996 | 521 | 0.100 |
Why?
|
| Nerve Growth Factors | 1 | 2014 | 565 | 0.090 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2014 | 263 | 0.090 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2016 | 777 | 0.090 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2013 | 169 | 0.090 |
Why?
|
| Facial Transplantation | 1 | 2014 | 221 | 0.090 |
Why?
|
| Pancreatic Cyst | 1 | 1995 | 373 | 0.090 |
Why?
|
| Aged, 80 and over | 18 | 2018 | 59489 | 0.090 |
Why?
|
| Eye Proteins | 1 | 2014 | 628 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2013 | 9373 | 0.090 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2015 | 392 | 0.090 |
Why?
|
| Lymph Nodes | 3 | 2014 | 3454 | 0.090 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2010 | 476 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2011 | 190 | 0.090 |
Why?
|
| Steroids | 2 | 2013 | 933 | 0.090 |
Why?
|
| False Negative Reactions | 4 | 2019 | 573 | 0.090 |
Why?
|
| Vulvar Diseases | 2 | 2003 | 66 | 0.090 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1997 | 790 | 0.090 |
Why?
|
| Cytoplasm | 3 | 2001 | 1500 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 7599 | 0.080 |
Why?
|
| Thyroid Gland | 1 | 1997 | 1180 | 0.080 |
Why?
|
| Eosinophilia | 1 | 1994 | 556 | 0.080 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2011 | 173 | 0.080 |
Why?
|
| Nose Diseases | 1 | 2010 | 79 | 0.080 |
Why?
|
| Arm | 1 | 2012 | 589 | 0.080 |
Why?
|
| Cytomegalovirus Infections | 1 | 1996 | 836 | 0.080 |
Why?
|
| Cell Line, Tumor | 11 | 2016 | 17075 | 0.080 |
Why?
|
| Sarcoma | 1 | 2000 | 1802 | 0.080 |
Why?
|
| Thyroid Nodule | 1 | 1997 | 779 | 0.080 |
Why?
|
| Cutis Laxa | 1 | 2009 | 29 | 0.080 |
Why?
|
| Borrelia burgdorferi | 1 | 2011 | 184 | 0.080 |
Why?
|
| Heat-Shock Proteins | 1 | 2013 | 791 | 0.080 |
Why?
|
| Suppuration | 1 | 2008 | 61 | 0.080 |
Why?
|
| Kidney | 3 | 1999 | 7066 | 0.080 |
Why?
|
| Neural Crest | 1 | 2011 | 278 | 0.080 |
Why?
|
| Genes, p53 | 2 | 2011 | 711 | 0.080 |
Why?
|
| Inflammation | 1 | 2008 | 10850 | 0.080 |
Why?
|
| Tuberous Sclerosis | 1 | 2016 | 1038 | 0.080 |
Why?
|
| Remission, Spontaneous | 2 | 2015 | 386 | 0.080 |
Why?
|
| Reproducibility of Results | 6 | 2016 | 20124 | 0.080 |
Why?
|
| Mucous Membrane | 1 | 2012 | 657 | 0.080 |
Why?
|
| Apocrine Glands | 1 | 2008 | 32 | 0.070 |
Why?
|
| Antigens, CD1 | 1 | 2011 | 435 | 0.070 |
Why?
|
| Mice | 19 | 2016 | 81819 | 0.070 |
Why?
|
| Papillomavirus Infections | 2 | 2015 | 1640 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2002 | 2975 | 0.070 |
Why?
|
| Introns | 1 | 2010 | 966 | 0.070 |
Why?
|
| Forecasting | 1 | 2017 | 2936 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1997 | 1560 | 0.070 |
Why?
|
| Gene Amplification | 3 | 2010 | 1091 | 0.070 |
Why?
|
| Predictive Value of Tests | 4 | 2015 | 15398 | 0.070 |
Why?
|
| Genes, myc | 1 | 2008 | 393 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 1490 | 0.070 |
Why?
|
| Cell Nucleus | 4 | 2001 | 2867 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 1995 | 0.070 |
Why?
|
| Prednisone | 2 | 2008 | 1565 | 0.070 |
Why?
|
| Transplantation, Homologous | 2 | 2016 | 4860 | 0.070 |
Why?
|
| Acid Phosphatase | 2 | 2011 | 139 | 0.070 |
Why?
|
| Herpes Simplex | 1 | 2010 | 472 | 0.070 |
Why?
|
| Activating Transcription Factor 1 | 1 | 2006 | 27 | 0.070 |
Why?
|
| Angiofibroma | 2 | 2016 | 57 | 0.070 |
Why?
|
| S100 Proteins | 3 | 2002 | 217 | 0.070 |
Why?
|
| Microsurgery | 1 | 2012 | 795 | 0.070 |
Why?
|
| Skin Transplantation | 1 | 2012 | 1098 | 0.070 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2006 | 76 | 0.070 |
Why?
|
| Carcinoma | 2 | 1999 | 2312 | 0.070 |
Why?
|
| Nose | 1 | 2010 | 519 | 0.070 |
Why?
|
| Animals | 24 | 2016 | 168764 | 0.060 |
Why?
|
| Karyotyping | 2 | 1998 | 1178 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1998 | 2329 | 0.060 |
Why?
|
| Pyridines | 1 | 2018 | 2888 | 0.060 |
Why?
|
| Signal Transduction | 10 | 2016 | 23601 | 0.060 |
Why?
|
| Pyrimidines | 2 | 2009 | 3047 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2016 | 3141 | 0.060 |
Why?
|
| Antineoplastic Agents | 3 | 2018 | 13648 | 0.060 |
Why?
|
| Hyperpigmentation | 1 | 2007 | 117 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2009 | 723 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 1140 | 0.060 |
Why?
|
| Lymphoma, T-Cell | 1 | 2008 | 309 | 0.060 |
Why?
|
| Tissue Donors | 2 | 2014 | 2395 | 0.060 |
Why?
|
| Face | 1 | 2011 | 1028 | 0.060 |
Why?
|
| Erythema Chronicum Migrans | 2 | 2011 | 50 | 0.060 |
Why?
|
| Computational Biology | 1 | 2017 | 3559 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2011 | 1028 | 0.060 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2008 | 548 | 0.060 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2006 | 212 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 1167 | 0.060 |
Why?
|
| Scleroderma, Systemic | 1 | 2008 | 346 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 1927 | 0.060 |
Why?
|
| Melanoma-Specific Antigens | 2 | 2001 | 75 | 0.060 |
Why?
|
| Mastocytosis | 1 | 2006 | 151 | 0.060 |
Why?
|
| Cell Lineage | 3 | 2011 | 2573 | 0.060 |
Why?
|
| Hair Color | 1 | 2004 | 132 | 0.060 |
Why?
|
| Carcinoma, Verrucous | 1 | 2004 | 27 | 0.060 |
Why?
|
| alpha-Galactosidase | 1 | 2004 | 59 | 0.060 |
Why?
|
| Antirheumatic Agents | 1 | 2013 | 1365 | 0.050 |
Why?
|
| Vulva | 2 | 2018 | 86 | 0.050 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2008 | 451 | 0.050 |
Why?
|
| Blister | 2 | 2015 | 90 | 0.050 |
Why?
|
| Mitochondria | 2 | 2016 | 3673 | 0.050 |
Why?
|
| Fabry Disease | 1 | 2004 | 90 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 1997 | 2371 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2008 | 995 | 0.050 |
Why?
|
| RNA Interference | 4 | 2015 | 2832 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3655 | 0.050 |
Why?
|
| Regeneration | 1 | 2012 | 1517 | 0.050 |
Why?
|
| Prognosis | 8 | 2015 | 29922 | 0.050 |
Why?
|
| Software | 1 | 2017 | 4462 | 0.050 |
Why?
|
| Hypopigmentation | 1 | 2002 | 43 | 0.050 |
Why?
|
| Histiocytosis, Sinus | 1 | 2002 | 45 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2017 | 2659 | 0.050 |
Why?
|
| Lymphoma, B-Cell | 1 | 2009 | 943 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 2428 | 0.050 |
Why?
|
| Child | 11 | 2020 | 80564 | 0.050 |
Why?
|
| Follow-Up Studies | 6 | 2017 | 39193 | 0.050 |
Why?
|
| Pathology, Surgical | 1 | 2003 | 147 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 4528 | 0.050 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2015 | 306 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 2 | 1998 | 5444 | 0.050 |
Why?
|
| Lung Neoplasms | 3 | 2017 | 13451 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 1744 | 0.040 |
Why?
|
| RNA, Small Interfering | 3 | 2015 | 3421 | 0.040 |
Why?
|
| Benzamides | 3 | 2015 | 1377 | 0.040 |
Why?
|
| Erythema | 2 | 2015 | 262 | 0.040 |
Why?
|
| Xanthogranuloma, Juvenile | 1 | 2000 | 17 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2014 | 4499 | 0.040 |
Why?
|
| Mitosis | 2 | 2004 | 1173 | 0.040 |
Why?
|
| Tumor Virus Infections | 1 | 2003 | 440 | 0.040 |
Why?
|
| Flutamide | 1 | 2000 | 96 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2007 | 2942 | 0.040 |
Why?
|
| Mice, Nude | 3 | 2012 | 3618 | 0.040 |
Why?
|
| Cell Proliferation | 5 | 2016 | 10429 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2016 | 323 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 1325 | 0.040 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2000 | 337 | 0.040 |
Why?
|
| Larva | 1 | 2001 | 511 | 0.040 |
Why?
|
| Quality Control | 2 | 2003 | 837 | 0.040 |
Why?
|
| Keratins | 1 | 2000 | 498 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2008 | 1808 | 0.040 |
Why?
|
| Gingivitis | 1 | 2019 | 126 | 0.040 |
Why?
|
| Leuprolide | 1 | 2000 | 312 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2012 | 11868 | 0.040 |
Why?
|
| Ticks | 1 | 1998 | 72 | 0.040 |
Why?
|
| Desmin | 1 | 1998 | 100 | 0.040 |
Why?
|
| Back | 1 | 2018 | 65 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2006 | 1608 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2015 | 7851 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2016 | 5753 | 0.040 |
Why?
|
| Crystallization | 1 | 1999 | 521 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2000 | 11083 | 0.040 |
Why?
|
| Young Adult | 4 | 2020 | 59889 | 0.040 |
Why?
|
| Fasciitis, Necrotizing | 1 | 1998 | 80 | 0.040 |
Why?
|
| Bites and Stings | 1 | 1998 | 95 | 0.040 |
Why?
|
| Immunosuppressive Agents | 2 | 2013 | 4209 | 0.040 |
Why?
|
| Postpartum Period | 2 | 2002 | 1205 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 1998 | 696 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2015 | 2014 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2006 | 2446 | 0.030 |
Why?
|
| Antibodies, Bacterial | 3 | 1998 | 1476 | 0.030 |
Why?
|
| Precancerous Conditions | 1 | 2004 | 976 | 0.030 |
Why?
|
| Base Sequence | 3 | 2014 | 12403 | 0.030 |
Why?
|
| Genome, Human | 1 | 2010 | 4448 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2012 | 6113 | 0.030 |
Why?
|
| Melanocyte-Stimulating Hormones | 2 | 2006 | 28 | 0.030 |
Why?
|
| Immunologic Factors | 2 | 2017 | 1587 | 0.030 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2016 | 31 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2016 | 2927 | 0.030 |
Why?
|
| Stem Cells | 2 | 2011 | 3540 | 0.030 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 1997 | 69 | 0.030 |
Why?
|
| Cytogenetics | 1 | 1996 | 198 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 10261 | 0.030 |
Why?
|
| Genomics | 3 | 2010 | 5929 | 0.030 |
Why?
|
| Mice, SCID | 2 | 2015 | 2630 | 0.030 |
Why?
|
| Umbilical Cord | 1 | 1997 | 180 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2006 | 2900 | 0.030 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 1997 | 218 | 0.030 |
Why?
|
| Amputation Stumps | 1 | 2015 | 39 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2009 | 5696 | 0.030 |
Why?
|
| Endometrium | 1 | 1998 | 406 | 0.030 |
Why?
|
| Alleles | 1 | 2006 | 6897 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2005 | 2850 | 0.030 |
Why?
|
| Fetal Death | 1 | 1997 | 435 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 8529 | 0.030 |
Why?
|
| Mitotic Index | 1 | 2015 | 159 | 0.030 |
Why?
|
| Lipoma | 1 | 1997 | 294 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 1996 | 405 | 0.030 |
Why?
|
| Retreatment | 1 | 2016 | 598 | 0.030 |
Why?
|
| Sulfonamides | 2 | 2016 | 1984 | 0.030 |
Why?
|
| Thorax | 1 | 2018 | 554 | 0.030 |
Why?
|
| Wilms Tumor | 1 | 1997 | 379 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2010 | 3785 | 0.030 |
Why?
|
| Dioxoles | 1 | 2015 | 98 | 0.030 |
Why?
|
| HEK293 Cells | 2 | 2015 | 4260 | 0.030 |
Why?
|
| Cell Differentiation | 4 | 2011 | 11641 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 1999 | 1153 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2012 | 5020 | 0.030 |
Why?
|
| Tyrosine | 1 | 1999 | 1428 | 0.030 |
Why?
|
| Thigh | 1 | 2015 | 238 | 0.030 |
Why?
|
| Transplantation Immunology | 1 | 2016 | 541 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2008 | 2310 | 0.030 |
Why?
|
| Specimen Handling | 1 | 1998 | 704 | 0.030 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2015 | 200 | 0.030 |
Why?
|
| Actins | 2 | 1998 | 2056 | 0.030 |
Why?
|
| Energy Metabolism | 2 | 2016 | 2892 | 0.030 |
Why?
|
| Cell Movement | 2 | 2016 | 5194 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 18071 | 0.030 |
Why?
|
| Apoptosis | 4 | 2013 | 9514 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 11888 | 0.030 |
Why?
|
| Melanins | 2 | 2006 | 293 | 0.030 |
Why?
|
| DNA Primers | 2 | 2011 | 2825 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2004 | 2590 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 3797 | 0.030 |
Why?
|
| Gene Dosage | 2 | 2010 | 1216 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 1056 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2012 | 3608 | 0.030 |
Why?
|
| Melanoma, Experimental | 2 | 2006 | 558 | 0.030 |
Why?
|
| Cysts | 1 | 1999 | 684 | 0.030 |
Why?
|
| Animals, Genetically Modified | 2 | 2011 | 1560 | 0.030 |
Why?
|
| Cartilage | 1 | 1996 | 798 | 0.030 |
Why?
|
| Bile Duct Neoplasms | 1 | 1998 | 626 | 0.030 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2012 | 59 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2012 | 13 | 0.030 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2014 | 178 | 0.030 |
Why?
|
| Arthritis | 1 | 2018 | 677 | 0.030 |
Why?
|
| Diabetes, Gestational | 1 | 2002 | 1263 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 1997 | 1866 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2000 | 1534 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2000 | 2920 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2012 | 381 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 17594 | 0.020 |
Why?
|
| Skin Ulcer | 1 | 2013 | 130 | 0.020 |
Why?
|
| Integrins | 1 | 2016 | 840 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 6 | 2015 | 22332 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 5783 | 0.020 |
Why?
|
| Blood Vessels | 1 | 1997 | 1113 | 0.020 |
Why?
|
| Neurofibromin 1 | 1 | 2012 | 190 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 2009 | 5197 | 0.020 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1996 | 730 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 1999 | 2242 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2013 | 591 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 1997 | 2352 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2012 | 8278 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2000 | 2464 | 0.020 |
Why?
|
| Recurrence | 2 | 2016 | 8501 | 0.020 |
Why?
|
| Drug Eruptions | 1 | 2013 | 335 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2014 | 669 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2016 | 2587 | 0.020 |
Why?
|
| Carcinogens | 1 | 2012 | 452 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 18293 | 0.020 |
Why?
|
| Myeloproliferative Disorders | 1 | 2016 | 616 | 0.020 |
Why?
|
| Mupirocin | 1 | 2010 | 56 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2011 | 4137 | 0.020 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2014 | 728 | 0.020 |
Why?
|
| DNA, Neoplasm | 2 | 2006 | 1742 | 0.020 |
Why?
|
| Radiography | 2 | 1999 | 6919 | 0.020 |
Why?
|
| Vascular Malformations | 1 | 2015 | 471 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 1994 | 1477 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2011 | 545 | 0.020 |
Why?
|
| Ki-67 Antigen | 2 | 2003 | 629 | 0.020 |
Why?
|
| ROC Curve | 1 | 1997 | 3620 | 0.020 |
Why?
|
| Injections | 1 | 2012 | 840 | 0.020 |
Why?
|
| Probability | 1 | 2015 | 2475 | 0.020 |
Why?
|
| Isoxazoles | 1 | 2011 | 234 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2010 | 202 | 0.020 |
Why?
|
| Acyclovir | 1 | 2010 | 267 | 0.020 |
Why?
|
| Mice, Knockout | 3 | 2012 | 14448 | 0.020 |
Why?
|
| Elastic Tissue | 1 | 2009 | 66 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2011 | 647 | 0.020 |
Why?
|
| Aging | 2 | 2004 | 8731 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 857 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2011 | 348 | 0.020 |
Why?
|
| NFATC Transcription Factors | 1 | 2010 | 392 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2013 | 1831 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2014 | 1505 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2011 | 6493 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 870 | 0.020 |
Why?
|
| Leukemia | 1 | 2016 | 1522 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2011 | 1160 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 2627 | 0.020 |
Why?
|
| Atrophy | 1 | 2012 | 1635 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 891 | 0.020 |
Why?
|
| beta-Endorphin | 1 | 2007 | 44 | 0.020 |
Why?
|
| Foreskin | 1 | 2007 | 33 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 2009 | 332 | 0.020 |
Why?
|
| Lymphoma | 1 | 2016 | 1897 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 74840 | 0.020 |
Why?
|
| COS Cells | 1 | 2009 | 1136 | 0.020 |
Why?
|
| Methotrexate | 1 | 2013 | 1722 | 0.020 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2007 | 140 | 0.020 |
Why?
|
| Zebrafish | 2 | 2011 | 3036 | 0.020 |
Why?
|
| alpha-MSH | 1 | 2007 | 72 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2011 | 1689 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2015 | 2394 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 1740 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 1870 | 0.020 |
Why?
|
| Simplexvirus | 1 | 2010 | 807 | 0.020 |
Why?
|
| Plasmids | 1 | 2011 | 2274 | 0.020 |
Why?
|
| SOXE Transcription Factors | 1 | 2006 | 75 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 1997 | 2098 | 0.020 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1998 | 2187 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2016 | 4159 | 0.020 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2006 | 121 | 0.020 |
Why?
|
| High Mobility Group Proteins | 1 | 2006 | 180 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 2013 | 981 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 595 | 0.020 |
Why?
|
| Vincristine | 1 | 2008 | 1039 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2007 | 5786 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 2005 | 2548 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2008 | 823 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2016 | 65188 | 0.010 |
Why?
|
| Dermatology | 1 | 2015 | 907 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 1066 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 2010 | 1144 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 2140 | 0.010 |
Why?
|
| Thymosin | 1 | 1985 | 48 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 1602 | 0.010 |
Why?
|
| Pregnancy | 3 | 2002 | 30260 | 0.010 |
Why?
|
| Dysplastic Nevus Syndrome | 1 | 2004 | 60 | 0.010 |
Why?
|
| Hair Diseases | 1 | 2005 | 73 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2006 | 704 | 0.010 |
Why?
|
| Trihexosylceramides | 1 | 2004 | 30 | 0.010 |
Why?
|
| Disease Progression | 3 | 2010 | 13632 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2005 | 323 | 0.010 |
Why?
|
| Vibrissae | 1 | 2004 | 122 | 0.010 |
Why?
|
| Genes, ras | 1 | 2006 | 658 | 0.010 |
Why?
|
| Genitalia, Female | 1 | 2004 | 147 | 0.010 |
Why?
|
| Cell Shape | 1 | 2004 | 373 | 0.010 |
Why?
|
| Medical Oncology | 1 | 2015 | 2339 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2011 | 2195 | 0.010 |
Why?
|
| Genome | 1 | 2011 | 1753 | 0.010 |
Why?
|
| Anemia, Aplastic | 1 | 2005 | 232 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6203 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2011 | 1889 | 0.010 |
Why?
|
| Cyclin E | 1 | 2003 | 156 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1998 | 4353 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2009 | 3067 | 0.010 |
Why?
|
| Perineum | 1 | 2004 | 213 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2016 | 3111 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2010 | 2666 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2005 | 778 | 0.010 |
Why?
|
| Keratinocytes | 1 | 2007 | 863 | 0.010 |
Why?
|
| Oxprenolol | 1 | 1982 | 2 | 0.010 |
Why?
|
| Mohs Surgery | 1 | 2005 | 219 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 4348 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2003 | 766 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 4392 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2008 | 2228 | 0.010 |
Why?
|
| Syndrome | 1 | 2008 | 3271 | 0.010 |
Why?
|
| Species Specificity | 1 | 2006 | 2406 | 0.010 |
Why?
|
| Swine | 1 | 2012 | 5988 | 0.010 |
Why?
|
| Methyldopa | 1 | 1981 | 19 | 0.010 |
Why?
|
| Monocytes | 1 | 2011 | 2595 | 0.010 |
Why?
|
| Tacrolimus | 1 | 2005 | 753 | 0.010 |
Why?
|
| Phenoxybenzamine | 1 | 1981 | 54 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 21056 | 0.010 |
Why?
|
| Fibrosis | 1 | 2008 | 2070 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2008 | 2230 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1886 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2004 | 744 | 0.010 |
Why?
|
| Survival Rate | 2 | 2008 | 12795 | 0.010 |
Why?
|
| Lymphatic Diseases | 1 | 2002 | 317 | 0.010 |
Why?
|
| Wound Healing | 1 | 2012 | 2792 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6499 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 4618 | 0.010 |
Why?
|
| Pain | 1 | 2015 | 5077 | 0.010 |
Why?
|
| Monophenol Monooxygenase | 1 | 2000 | 73 | 0.010 |
Why?
|
| Propranolol | 1 | 1982 | 492 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2003 | 703 | 0.010 |
Why?
|
| beta Catenin | 1 | 2005 | 1043 | 0.010 |
Why?
|
| Lipids | 1 | 2011 | 3315 | 0.010 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 702 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2011 | 2747 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 1652 | 0.010 |
Why?
|
| Remission Induction | 1 | 2005 | 2411 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2005 | 2505 | 0.010 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2000 | 281 | 0.010 |
Why?
|
| Missouri | 1 | 1998 | 113 | 0.010 |
Why?
|
| Ixodes | 1 | 1998 | 41 | 0.010 |
Why?
|
| Genotype | 1 | 2012 | 13024 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 1410 | 0.010 |
Why?
|
| Sirolimus | 1 | 2005 | 1545 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7425 | 0.010 |
Why?
|
| Insect Vectors | 1 | 1998 | 136 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2004 | 1499 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2012 | 5337 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 22223 | 0.010 |
Why?
|
| Amoxicillin | 1 | 1998 | 180 | 0.010 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 1997 | 100 | 0.010 |
Why?
|
| Time Factors | 2 | 1997 | 40065 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1985 | 1387 | 0.010 |
Why?
|
| Urinary Incontinence | 1 | 1981 | 491 | 0.010 |
Why?
|
| Vimentin | 1 | 1997 | 258 | 0.010 |
Why?
|
| Culture Media | 1 | 1998 | 890 | 0.010 |
Why?
|
| Doxycycline | 1 | 1998 | 349 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 2003 | 1275 | 0.010 |
Why?
|
| Kidney Diseases, Cystic | 1 | 1997 | 183 | 0.010 |
Why?
|
| Debridement | 1 | 1998 | 495 | 0.010 |
Why?
|
| Cell Survival | 1 | 2005 | 5747 | 0.010 |
Why?
|
| Maternal Mortality | 1 | 1998 | 313 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9525 | 0.010 |
Why?
|
| Contrast Media | 1 | 2008 | 5329 | 0.010 |
Why?
|
| Penicillins | 1 | 1998 | 404 | 0.010 |
Why?
|
| Infant | 1 | 1997 | 36386 | 0.010 |
Why?
|
| Rats | 1 | 2011 | 23707 | 0.010 |
Why?
|
| Pregnancy Trimester, Second | 1 | 1997 | 737 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1997 | 42500 | 0.010 |
Why?
|
| Peroxidase | 1 | 1997 | 606 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2017 | 41649 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1998 | 54802 | 0.010 |
Why?
|
| Gene Expression | 1 | 2006 | 7584 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 1999 | 1394 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2009 | 18973 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2004 | 12437 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 15543 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 4520 | 0.010 |
Why?
|
| Seasons | 1 | 1998 | 1524 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 9550 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 12768 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 4427 | 0.010 |
Why?
|
| Calcinosis | 1 | 1999 | 1479 | 0.010 |
Why?
|
| Adipocytes | 1 | 1997 | 1194 | 0.010 |
Why?
|
| Mast Cells | 1 | 1997 | 1412 | 0.010 |
Why?
|
| Models, Biological | 1 | 2005 | 9443 | 0.000 |
Why?
|
| Age Factors | 1 | 2004 | 18380 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1999 | 5993 | 0.000 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 16047 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1987 | 939 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 36532 | 0.000 |
Why?
|
| Tetanus Toxoid | 1 | 1985 | 188 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2004 | 26346 | 0.000 |
Why?
|
| Antibody Specificity | 1 | 1985 | 1061 | 0.000 |
Why?
|
| Bacterial Vaccines | 1 | 1985 | 400 | 0.000 |
Why?
|
| Aerosols | 1 | 1985 | 633 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1999 | 8923 | 0.000 |
Why?
|
| Hypertension | 1 | 1982 | 8626 | 0.000 |
Why?
|
| Pneumococcal Vaccines | 1 | 1985 | 414 | 0.000 |
Why?
|
| Sympathectomy | 1 | 1981 | 73 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1998 | 7478 | 0.000 |
Why?
|
| Antigens, Bacterial | 1 | 1985 | 1146 | 0.000 |
Why?
|
| Streptococcus pneumoniae | 1 | 1985 | 762 | 0.000 |
Why?
|
| Posture | 1 | 1982 | 954 | 0.000 |
Why?
|
| Random Allocation | 1 | 1982 | 2395 | 0.000 |
Why?
|
| Neovascularization, Pathologic | 1 | 1987 | 2631 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1981 | 1417 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1999 | 20659 | 0.000 |
Why?
|
| Immunity, Innate | 1 | 1985 | 3081 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1982 | 8041 | 0.000 |
Why?
|